ACHE and Alzheimer disease: Finally, preliminary results from the comparison among G1, G2, and G3 groups appeared to display that almost all proteoforms found at high levels in the AD saliva were more concentrated in G1 and G2, treated with AChE inhibitors, than in G3 group; this last group, treated with an NMDAR antagonist, showed levels similar to those of the HC group.